Trial record 1 of 1 for: AC220-A-U302 Quizartinib With Standard of Care Chemotherapy and as Maintenance Therapy in Patients W
Payee Study Name Principal Investigator / Lead Researcher Last Name Principal Investigator / Lead Researcher First Name City of
TITULO CÓDIGO PROTOCOLO DEL ENSAYO SERVICIO Estudio abierto y multicéntrico en fase III de Brigatinib (AP26113) frente a Crizo
Report on the Deliberation Results June 3, 2019 Pharmaceutical Evaluation Division, Pharmaceutical Safety and Environmental Heal
![Clinical Trials, Study Results and Plain Language Results Summaries - Clinical Trials - Research & Development - Daiichi Sankyo Clinical Trials, Study Results and Plain Language Results Summaries - Clinical Trials - Research & Development - Daiichi Sankyo](https://www.daiichisankyo.com/files/news/ourstories/images/22_15_Taka-Diastase/history%20takadiastase.webp)